Literature DB >> 16033781

The association between APOE epsilon4, age and outcome after head injury: a prospective cohort study.

G M Teasdale1, G D Murray, J A R Nicoll.   

Abstract

Previous preliminary studies have suggested that possession of the APOE epsilon4 allele is associated with a poor outcome after head injury. This study was designed to confirm and extend those observations in a larger study with examination of additional variables. We prospectively identified admissions to a Neurosurgical Unit for head injury, collected demographic and clinical data, determined APOE genotypes and obtained follow-up information at 6 months. A total of 1094 subjects were enrolled (age range: 0-93 years, mean 37 years). Outcome was assessed using the Glasgow Outcome Scale. There was no overall association between APOE genotype and outcome, with 36% of APOE epsilon4 carriers having an unfavourable outcome compared with 33% of non-carriers of APOE epsilon4. However, there was evidence of an interaction between age and APOE genotype on outcome (P = 0.007) such that possession of APOE epsilon4 reduced the prospect of a favourable outcome in children and young adults. The influence of APOE genotype in younger patients after head injury can be expressed as, at age <15 years, carriage of APOE epsilon4 being equivalent to ageing by 25 years. This finding is consistent with experimental data suggesting that the effect of APOE genotype on outcome after head injury may be expressed through the processes of repair and recovery.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16033781     DOI: 10.1093/brain/awh595

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  65 in total

1.  Neuroinflammatory Cytokines-The Common Thread in Alzheimer's Pathogenesis.

Authors:  W Sue T Griffin; Steven W Barger
Journal:  US Neurol       Date:  2010

2.  Does the extended Glasgow Outcome Scale add value to the conventional Glasgow Outcome Scale?

Authors:  James Weir; Ewout W Steyerberg; Isabella Butcher; Juan Lu; Hester F Lingsma; Gillian S McHugh; Bob Roozenbeek; Andrew I R Maas; Gordon D Murray
Journal:  J Neurotrauma       Date:  2012-01-01       Impact factor: 5.269

Review 3.  Chronic traumatic encephalopathy: a potential late effect of sport-related concussive and subconcussive head trauma.

Authors:  Brandon E Gavett; Robert A Stern; Ann C McKee
Journal:  Clin Sports Med       Date:  2011-01       Impact factor: 2.182

4.  Apolipoprotein E4 and traumatic brain injury.

Authors:  H Houlden; R Greenwood
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-06-22       Impact factor: 10.154

Review 5.  Management of pediatric mild traumatic brain injury: a neuropsychological review from injury through recovery.

Authors:  Michael W Kirkwood; Keith Owen Yeates; H Gerry Taylor; Christopher Randolph; Michael McCrea; Vicki A Anderson
Journal:  Clin Neuropsychol       Date:  2007-09-01       Impact factor: 3.535

Review 6.  Genetic influences on outcome following traumatic brain injury.

Authors:  Barry D Jordan
Journal:  Neurochem Res       Date:  2007-03-07       Impact factor: 3.996

7.  The influence of apolipoprotein E genotype on visuospatial attention dissipates after age 80.

Authors:  Selam Negash; Pamela M Greenwood; Trey Sunderland; Raja Parasuraman; Yonas E Geda; David S Knopman; Bradley F Boeve; Robert J Ivnik; Ronald C Petersen; Glenn E Smith
Journal:  Neuropsychology       Date:  2009-01       Impact factor: 3.295

8.  Apolipoprotein E polymorphisms and severity of cerebral palsy: a cross-sectional study in 255 children in Norway.

Authors:  Espen Lien; Guro L Andersen; Yongde Bao; Heather Gordish-Dressman; Jon S Skranes; Torstein Vik; James A Blackman
Journal:  Dev Med Child Neurol       Date:  2013-02-05       Impact factor: 5.449

9.  Human apolipoprotein E4 worsens acute axonal pathology but not amyloid-β immunoreactivity after traumatic brain injury in 3xTG-AD mice.

Authors:  Rachel E Bennett; Thomas J Esparza; Hal A Lewis; Eddie Kim; Christine L Mac Donald; Patrick M Sullivan; David L Brody
Journal:  J Neuropathol Exp Neurol       Date:  2013-05       Impact factor: 3.685

10.  Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity.

Authors:  Stella E Panos; Charles H Hinkin; Elyse J Singer; April D Thames; Sapna M Patel; Janet S Sinsheimer; A C Del Re; Benjamin B Gelman; Susan Morgello; David J Moore; Andrew J Levine
Journal:  Neurobehav HIV Med       Date:  2013-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.